DCAT Value Chain Insights

The Pharma Pulse: Precision Medicine and Manufacturing

What may the future hold for manufacturing lower-volume drugs created by personalized medicines and more targeted therapies? Are smaller batch runs simply the answer or how may manufacturing evolve...

The EU: Manufacturing and Preparing for the Next Health Emergency

The European Commission has launched the European Health Emergency preparedness and Response Authority (HERA) for ensuring the development, production and distribution of medicines, vaccines and...

SPONSORED CONTENT

Monoclonal Antibody Manufacturing for BioPharma: To Build or Outsource?

Information
September 8, 2021
Sponsored by Samsung Biologics

As the global biologics market continues to grow, securing speed with scale has never been a greater priority. Here we demonstrate important factors to consider in making optimal outsourcing...

Read More
Feeling Pressure To Shorten Early Development Timelines?

Information
August 11, 2021
Sponsored by Thermo Fisher Scientific

Lengthy early-development timelines are common across new and emerging biotech companies for a multitude of reasons. Striking the right balance of speed, quality, risk, and investment allows you to...

Read More
Expand Opportunities with a Strong CMO Relationship

Information
July 28, 2021
Sponsored by CMIC CMO USA

Pharmaceutical and biopharmaceutical companies have been extensively using contract research organizations (CROs) to meet their challenging needs in R&D and standard work for several decades. A...

Read More